668 related articles for article (PubMed ID: 23910335)
61. Biodegradable network elastomeric polyesters from multifunctional aliphatic carboxylic acids and poly(epsilon-caprolactone) diols.
Nagata M; Kato K; Sakai W; Tsutsumi N
Macromol Biosci; 2006 May; 6(5):333-9. PubMed ID: 16676379
[TBL] [Abstract][Full Text] [Related]
62. Sol-gel derived nanoscale bioactive glass (NBG) particles reinforced poly(ε-caprolactone) composites for bone tissue engineering.
Lei B; Shin KH; Noh DY; Jo IH; Koh YH; Kim HE; Kim SE
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1102-8. PubMed ID: 23827548
[TBL] [Abstract][Full Text] [Related]
63. The degradation and biocompatibility of pH-sensitive biodegradable polyurethanes for intracellular multifunctional antitumor drug delivery.
Zhou L; Liang D; He X; Li J; Tan H; Li J; Fu Q; Gu Q
Biomaterials; 2012 Mar; 33(9):2734-45. PubMed ID: 22236829
[TBL] [Abstract][Full Text] [Related]
64. Coalesced poly(ε-caprolactone) fibers are stronger.
Gurarslan A; Caydamli Y; Shen J; Tse S; Yetukuri M; Tonelli AE
Biomacromolecules; 2015 Mar; 16(3):890-3. PubMed ID: 25615714
[TBL] [Abstract][Full Text] [Related]
65. In vitro degradation and biocompatibility of poly(DL-lactide-epsilon-caprolactone) nerve guides.
Meek MF; Jansen K; Steendam R; van Oeveren W; van Wachem PB; van Luyn MJ
J Biomed Mater Res A; 2004 Jan; 68(1):43-51. PubMed ID: 14661248
[TBL] [Abstract][Full Text] [Related]
66. Electrospun poly(epsilon-caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering.
Ghasemi-Mobarakeh L; Prabhakaran MP; Morshed M; Nasr-Esfahani MH; Ramakrishna S
Biomaterials; 2008 Dec; 29(34):4532-9. PubMed ID: 18757094
[TBL] [Abstract][Full Text] [Related]
67. Evaluation of a novel poly(epsilon-caprolactone)-organosiloxane hybrid material for the potential application as a bioactive and degradable bone substitute.
Rhee SH; Lee YK; Lim BS; Yoo JJ; Kim HJ
Biomacromolecules; 2004; 5(4):1575-9. PubMed ID: 15244480
[TBL] [Abstract][Full Text] [Related]
68. A new generation of poly(lactide/ε-caprolactone) polymeric biomaterials for application in the medical field.
Fernández J; Larrañaga A; Etxeberria A; Wang W; Sarasua JR
J Biomed Mater Res A; 2014 Oct; 102(10):3573-84. PubMed ID: 24243562
[TBL] [Abstract][Full Text] [Related]
69. Synthesis and characterizations of biodegradable and crosslinkable poly(epsilon-caprolactone fumarate), poly(ethylene glycol fumarate), and their amphiphilic copolymer.
Wang S; Lu L; Gruetzmacher JA; Currier BL; Yaszemski MJ
Biomaterials; 2006 Feb; 27(6):832-41. PubMed ID: 16102819
[TBL] [Abstract][Full Text] [Related]
70. Poly(ε-caprolactone)/triclosan loaded polylactic acid nanoparticles composite: A long-term antibacterial bionanocomposite with sustained release.
Kaffashi B; Davoodi S; Oliaei E
Int J Pharm; 2016 Jul; 508(1-2):10-21. PubMed ID: 27155590
[TBL] [Abstract][Full Text] [Related]
71. Melt spinning of poly(lactic acid) and hydroxyapatite composite fibers: influence of the filler content on the fiber properties.
Persson M; Lorite GS; Cho SW; Tuukkanen J; Skrifvars M
ACS Appl Mater Interfaces; 2013 Aug; 5(15):6864-72. PubMed ID: 23848437
[TBL] [Abstract][Full Text] [Related]
72. Formation of and coalescence from the inclusion complex of a biodegradable block copolymer and alpha-cyclodextrin. 2: A novel way to regulate the biodegradation behavior of biodegradable block copolymers.
Shuai X; Wei M; Porbeni FE; Bullions TA; Tonelli AE
Biomacromolecules; 2002; 3(1):201-7. PubMed ID: 11866574
[TBL] [Abstract][Full Text] [Related]
73.
Conde G; de Carvalho JRG; Dias PDP; Moranza HG; Montanhim GL; Ribeiro JO; Chinelatto MA; Moraes PC; Taboga SR; Bertolo PHL; Gonçalves Funnicelli MI; Pinheiro DG; Ferraz GC
Biomed Phys Eng Express; 2021 Mar; 7(3):. PubMed ID: 33652429
[TBL] [Abstract][Full Text] [Related]
74. Fabrication of Poly(
Morouço P; Biscaia S; Viana T; Franco M; Malça C; Mateus A; Moura C; Ferreira FC; Mitchell G; Alves NM
Biomed Res Int; 2016; 2016():1596157. PubMed ID: 27872844
[TBL] [Abstract][Full Text] [Related]
75. Star-shaped PCL/PLLA blended fiber membrane via electrospinning.
Li H; Qiao T; Song P; Guo H; Song X; Zhang B; Chen X
J Biomater Sci Polym Ed; 2015; 26(7):420-32. PubMed ID: 25671790
[TBL] [Abstract][Full Text] [Related]
76. An injectable biodegradable temperature-responsive gel with an adjustable persistence window.
Kim JI; Kim DY; Kwon DY; Kang HJ; Kim JH; Min BH; Kim MS
Biomaterials; 2012 Apr; 33(10):2823-34. PubMed ID: 22261098
[TBL] [Abstract][Full Text] [Related]
77. Effect of diameter of poly(lactic acid) fiber on the physical properties of poly(ɛ-caprolactone).
Ju D; Han L; Guo Z; Bian J; Li F; Chen S; Dong L
Int J Biol Macromol; 2015 May; 76():49-57. PubMed ID: 25709010
[TBL] [Abstract][Full Text] [Related]
78. Melt electrowriting of a biocompatible photo-crosslinkable poly(D,L-lactic acid)/poly(ε-caprolactone)-based material with tunable mechanical and functionalization properties.
Darroch C; Asaro GA; Gréant C; Suku M; Pien N; van Vlierberghe S; Monaghan MG
J Biomed Mater Res A; 2023 Jun; 111(6):851-862. PubMed ID: 36951312
[TBL] [Abstract][Full Text] [Related]
79. Compatibilized polymer blends based on PDLLA and PCL for application in bioartificial liver.
Calandrelli L; Calarco A; Laurienzo P; Malinconico M; Petillo O; Peluso G
Biomacromolecules; 2008 Jun; 9(6):1527-34. PubMed ID: 18494521
[TBL] [Abstract][Full Text] [Related]
80. Printability and Critical Insight into Polymer Properties during Direct-Extrusion Based 3D Printing of Medical Grade Polylactide and Copolyesters.
Jain S; Fuoco T; Yassin MA; Mustafa K; Finne-Wistrand A
Biomacromolecules; 2020 Feb; 21(2):388-396. PubMed ID: 31566357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
